Immunohistochemical evaluation of AKT protein activation in canine mast cell tumours

J Comp Pathol. 2012 Aug-Oct;147(2-3):171-6. doi: 10.1016/j.jcpa.2011.12.003. Epub 2012 Jan 30.

Abstract

The pathogenesis of canine mast cell tumour (MCT) remains unknown. Moreover, therapeutic options are limited and resistance to targeted drugs and recurrences are common, necessitating the identification of additional cellular targets for therapy. In this study we investigated the expression of phosphorylated AKT protein in 25 archival canine MCT samples by immunohistochemistry and examined the correlation between the immunohistochemical scores and histopathological tumour grades. AKT protein was detected in all of the samples and 24 of the 25 samples expressed the phosphorylated form of the protein, albeit with variable intensity. However, when the immunohistochemical scores of weak, intermediate and strong labelling were compared with the histopathological grades I to III, there was no strong correlation. This study suggests that canine MCT cells have activated AKT and indicates the need for further research on the role of the AKT protein and the possibility of targeting the AKT signalling pathway in MCTs.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Biomarkers, Tumor / metabolism
  • Dog Diseases / metabolism
  • Dog Diseases / pathology*
  • Dogs
  • Female
  • Male
  • Mast Cells / metabolism
  • Mast Cells / pathology*
  • Mastocytoma / metabolism
  • Mastocytoma / pathology
  • Mastocytoma / veterinary*
  • Neoplasm Staging / veterinary
  • Proto-Oncogene Proteins c-akt / biosynthesis*

Substances

  • Biomarkers, Tumor
  • Proto-Oncogene Proteins c-akt